Skip to main content
. 2005 Mar;139(3):458–467. doi: 10.1111/j.1365-2249.2005.02733.x

Fig. 2.

Fig. 2

Peptide-pulsed CD40-activated B cells can act as alternative antigen-presenting cells. (a) IFN-γ production of PBMC primed with CMV pp65 mRNA-electroporated mature DC after restimulation with unloaded or with CMV pp65 peptide-pulsed T2 or autologous CD40-B cells. (b) IFN-γ production of PBMC primed with influenza M1 peptide-pulsed CD40-B cells after restimulation with unloaded or with influenza M1 peptide-pulsed T2 or autologous CD40-B cells. (c) IFN-γ production of PBMC primed with influenza HA peptide-pulsed CD40-B cells after restimulation with unloaded or with influenza HA peptide-pulsed autologous CD40-B cells. (d) IFN-γ production of PBMC primed with influenza HA peptide-pulsed CD40-B cells after restimulation with unloaded or with influenza HA peptide-pulsed allogeneic EBV-LCL. Graphs represent results from IFN-γ ELISA assays (error bars indicate standard deviation) and are representative of two individual experiments.